tradingkey.logo

Transmedics Group Inc

TMDX
View Detailed Chart
127.670USD
+6.600+5.45%
Close 12/19, 16:00ETQuotes delayed by 15 min
4.36BMarket Cap
47.17P/E TTM

Transmedics Group Inc

127.670
+6.600+5.45%
Intraday
1m
30m
1h
D
W
M
D

Today

+5.45%

5 Days

+0.69%

1 Month

-2.49%

6 Months

+3.33%

Year to Date

+104.76%

1 Year

+106.92%

View Detailed Chart

Key Insights

Transmedics Group Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 51/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 145.92.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Transmedics Group Inc's Score

Industry at a Glance

Industry Ranking
51 / 208
Overall Ranking
134 / 4582
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 14 analysts
Buy
Current Rating
145.917
Target Price
+6.82%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Transmedics Group Inc Highlights

StrengthsRisks
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 372.44% year-on-year.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Fairly Valued
The company’s latest PE is 47.17, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 37.62M shares, decreasing 17.85% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 479.00 shares of this stock.

Transmedics Group Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Transmedics Group Inc Info

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Ticker SymbolTMDX
CompanyTransmedics Group Inc
CEOHassanein (Waleed H)
Websitehttps://www.transmedics.com/

FAQs

What is the current price of Transmedics Group Inc (TMDX)?

The current price of Transmedics Group Inc (TMDX) is 127.670.

What is the symbol of Transmedics Group Inc?

The ticker symbol of Transmedics Group Inc is TMDX.

What is the 52-week high of Transmedics Group Inc?

The 52-week high of Transmedics Group Inc is 156.000.

What is the 52-week low of Transmedics Group Inc?

The 52-week low of Transmedics Group Inc is 55.000.

What is the market capitalization of Transmedics Group Inc?

The market capitalization of Transmedics Group Inc is 4.36B.

What is the net income of Transmedics Group Inc?

The net income of Transmedics Group Inc is 35.46M.

Is Transmedics Group Inc (TMDX) currently rated as Buy, Hold, or Sell?

According to analysts, Transmedics Group Inc (TMDX) has an overall rating of Buy, with a price target of 145.917.

What is the Earnings Per Share (EPS TTM) of Transmedics Group Inc (TMDX)?

The Earnings Per Share (EPS TTM) of Transmedics Group Inc (TMDX) is 2.707.
KeyAI